Karamitopoulou, Evanthia; Zlobec, I; Born, D; Kondi-Pafiti, A; Lykoudis, P; Mellou, A; Gennatas, K; Gloor, B; Lugli, A (2013). Tumour budding is a strong and independent prognostic factor in pancreatic cancer. European journal of cancer, 49(5), pp. 1032-9. Amsterdam: Elsevier 10.1016/j.ejca.2012.10.022
Full text not available from this repository. (Request a copy)Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that escapes detection and resists treatment. Tumour budding, defined as the presence of de-differentiated single tumour cells or small cell clusters at the invasive front of gastrointestinal carcinomas like colorectal, oesophageal, gastric and ampullary, is linked to adverse prognosis. Tumour budding has not yet been reported in PDAC.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology 04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Visceral Surgery |
UniBE Contributor: |
Karamitopoulou Diamantis, Evanthia, Zlobec, Inti, Born, Diana, Gloor, Beat, Lugli, Alessandro |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
0959-8049 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:32 |
Last Modified: |
02 Mar 2023 23:21 |
Publisher DOI: |
10.1016/j.ejca.2012.10.022 |
PubMed ID: |
23177090 |
Web of Science ID: |
000315945500006 |
URI: |
https://boris.unibe.ch/id/eprint/12478 (FactScience: 218827) |
Actions (login required)
 |
Edit item |